arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Core Laboratories Inc. /DE/

CLB

$8.93 ▼ -0.74 (-7.70%) at close

5 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

Core Laboratories Inc. /DE/ shows mixed fundamentals. Consider comparing against peers in the Energy sector before making investment decisions.

Market Cap $414.6M

Dividend Yield 0.45%

Revenue Growth 0.5% ↘

Op. Margin 10.7% ↘

ROIC 9.9% ↘

FCF / Share $0.56 ↘

Trailing P/E 14.0x

Price / Book 1.6x

FCF Yield 6.2%

Debt / Equity 0.42

info Valuation on last close. End-of-day price, Nov 5, 2026.

5-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$526.52M

↑ +0.5% —

Net Income Profit after all expenses

$29.67M

↓ -5.5% —

Operating Margin Operating profit as % of sales

10.7%

↓ -4.1% 58th

FCF / Share Free cash flow per share

$0.56

↓ -41.4% —

Long-Term Debt Long-term obligations

$113.00M

↓ -11.7% —

Health Breakdown

Profitability ↑

Returns ↑

Financial Health →

Cash Quality ↓

Dividend History

Dividend / share · sourced from SEC filings

$0.04 Latest / share

+0.0% YoY

+0.0% 5-yr CAGR

$0.04

FY 2021

$0.04

FY 2022

$0.04

FY 2023

$0.04

FY 2024

$0.04

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Revenue Growth YoY (%)	0.5% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-90%)	2.8% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-45%)	4.1% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-18%)	4.1% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-17%)	—
EPS Growth YoY (%)	-4.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-15.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	88.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-2.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—
Net Income Growth YoY (%)	-5.5% Weak ↓ Weak Declining Year-over-year change in net income	-14.4% Weak ↓ Weak Declining Year-over-year change in net income	88.5% Excellent Excellent Year-over-year change in net income	-1.4% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	-41.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	211.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-4.3% Weak Weak Year-over-year change in free cash flow	-36.5% Weak Weak Year-over-year change in free cash flow	—
Revenue CAGR 3Y (%)	2.4% Caution Caution Compound annual revenue growth over 3 years	3.7% Caution Caution Compound annual revenue growth over 3 years	—	—	—
EPS CAGR 3Y (%)	15.1% Excellent Excellent Compound annual EPS growth over 3 years	15.9% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Operating Margin (%) (%)	10.7% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-29%)	11.2% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-25%)	10.7% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-29%)	8.5% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-43%)	9.6% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-36%)
Effective Tax Rate (%) (%)	33.8% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	30.4% Weak → Weak Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	10.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	34.4% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	44.0% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	5.6% Caution → Caution Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-30%)	6.0% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-25%)	7.2% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-10%)	4.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-50%)	4.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-48%)
FCF Margin (%) (%)	4.9% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	8.5% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	2.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	3.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	4.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	0.87x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.42x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair Fair Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Return on Invested Capital (%)	9.9% Fair → Fair Stable Return earned on debt + equity capital invested Optimal: > 10%	10.9% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	12.6% Good Good Return earned on debt + equity capital invested Optimal: > 10%	7.6% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	9.7% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	10.0% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	9.3% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	7.2% Fair Fair Operating profit relative to total assets Optimal: > 10%	7.8% Fair Fair Operating profit relative to total assets Optimal: > 10%
Return on Common Equity (%) (%)	11.2% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-7%)	12.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+6%)	16.3% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+36%)	10.6% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-12%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Debt to Equity (x)	0.42x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-15%)	0.52x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.74x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+48%)	0.95x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+90%)	—
Interest Coverage (x)	5.34x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	4.73x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	4.07x Fair → Fair Stable Operating income divided by interest expense Optimal: > 5x	3.59x Fair Fair Operating income divided by interest expense Optimal: > 5x	4.95x Fair Fair Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$90.30M	$108.84M	$150.88M	$159.57M	—
Debt / EBITDA (x)	1.59x Good ↓ Good Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.74x Good ↓ Good Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.36x Fair Fair Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.98x Fair Fair Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Revenue per Share (USD)	$11.34	$11.17	$10.92	$10.57	$10.22
Basic EPS, GAAP (USD)	$0.64	$0.67	$0.79	$0.42	$0.43
Free Cash Flow per Share (USD)	$0.56	$0.95	$0.30	$0.32	$0.50
Dividend per Share (USD)	$0.04	$0.04	$0.04	$0.04	$0.04
Book Value per Share (USD)	$5.77	$5.27	$4.80	$3.95	—
Tangible Book Value per Share (USD)	$3.32	$3.01	$2.53	$1.66	—
Basic Weighted Avg Shares (shares)	46.43M	46.90M	46.68M	46.33M	46.01M

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Working Capital (USD)	$108.65M	$118.89M	$135.04M	$108.57M	—
LT Debt (USD)	$113.00M	$128.00M	$166.00M	$175.00M	—
Total Equity (USD)	$265.99M	$246.57M	$224.81M	$184.26M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Sales/Revenue/Turnover (USD)	$526.52M	$523.85M	$509.79M	$489.74M	$470.25M
Depreciation Expense (USD)	$14.65M	$14.95M	$15.78M	$17.16M	$18.52M
Net Income, GAAP (USD)	$29.67M	$31.40M	$36.67M	$19.45M	$19.73M
Operating Cash Flow (USD)	$37.03M	$56.39M	$24.79M	$24.96M	$36.58M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 5 years · 19 quarters

Core Laboratories Inc. /DE/

Analytical Summary

5-Year Financial Trajectory

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare CLB with peers